ResearcherUniversity Hospital OlomoucActive in the last 2 years

Aleš Langer

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2024: 2 papers · 2025: 2 papers

Papers 4

Potential for Clinical Management of Pancreatic Cancer Through Whole Exome Profiling of Site-Specific Metastases and Matched Primary Tumors. Co-author DOI 10.1016/j.labinv.2025.104205 ↗
Therapeutic pancreatic cancer biomarkers and pharmacogenetics. Co-author DOI 10.1016/j.semcancer.2025.08.002 ↗
Oligometastatic pancreatic cancer - prognostic factors for oncosurgical individualized therapy. Co-author DOI 10.48095/ccrvch2024421 ↗
Complete pathological response after neoadjuvant chemotherapy and the benefit of subsequent surgery in oligometastatic pancreatic cancer patient. Co-author DOI 10.48095/ccrvch2024454 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Martin Loveček · 3 shared papers, 2024–2025 · strength 0.72
Beatrice Mohelníková Duchoňová · 2 shared papers, 2024 · strength 0.50
- Paper Complete pathological response after neoadjuvant chemotherapy and the benefit of subsequent surgery in oligometastatic … DOI 10.48095/ccrvch2024454 ↗
- Paper Oligometastatic pancreatic cancer - prognostic factors for oncosurgical individualized therapy. DOI 10.48095/ccrvch2024421 ↗
Viktor Hlaváč · 2 shared papers, 2025 · strength 0.46
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
- Paper Potential for Clinical Management of Pancreatic Cancer Through Whole Exome Profiling of Site-Specific Metastases and Ma… DOI 10.1016/j.labinv.2025.104205 ↗
Pavel Souček · 2 shared papers, 2025 · strength 0.46
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
- Paper Potential for Clinical Management of Pancreatic Cancer Through Whole Exome Profiling of Site-Specific Metastases and Ma… DOI 10.1016/j.labinv.2025.104205 ↗
Beatrice Mohelníková-Duchoňová · 2 shared papers, 2025 · strength 0.46
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
- Paper Potential for Clinical Management of Pancreatic Cancer Through Whole Exome Profiling of Site-Specific Metastases and Ma… DOI 10.1016/j.labinv.2025.104205 ↗
Ștefania Bunduc · 1 shared paper, 2025 · strength 0.24
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
Michal Kroupa · 1 shared paper, 2025 · strength 0.24
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
Riccardo Farinella · 1 shared paper, 2025 · strength 0.24
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
Daniele Campa · 1 shared paper, 2025 · strength 0.24
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.24
- Paper Therapeutic pancreatic cancer biomarkers and pharmacogenetics. DOI 10.1016/j.semcancer.2025.08.002 ↗
Lenka Červenková · 1 shared paper, 2025 · strength 0.22
- Paper Potential for Clinical Management of Pancreatic Cancer Through Whole Exome Profiling of Site-Specific Metastases and Ma… DOI 10.1016/j.labinv.2025.104205 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.